PHRMASIPharmaceuticals
Pharmasia Ltd — Cash Flow Statement
₹75.20
+0.00%
Pharmasia Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -0.17 Cr | 0.07 Cr | 0.62 Cr | -0.18 Cr | — |
| Repayment Of Debt | 0.00 | -63000.00 | -0.15 Cr | 0.00 | — |
| Capital Expenditure | -0.17 Cr | -0.03 Cr | -0.03 Cr | — | — |
| End Cash Position | 0.36 Cr | 0.63 Cr | 0.69 Cr | 0.22 Cr | — |
| Other Cash Adjustment Outside Changein Cash | 1000.00 | -2000.00 | -2000.00 | -77000.00 | — |
| Beginning Cash Position | 0.63 Cr | 0.69 Cr | 0.22 Cr | 0.38 Cr | — |
| Changes In Cash | -0.27 Cr | -0.06 Cr | 0.48 Cr | -0.17 Cr | — |
| Financing Cash Flow | -0.15 Cr | -0.16 Cr | -0.16 Cr | 1000.00 | — |
| Interest Paid Cff | -0.02 Cr | -0.04 Cr | -0.02 Cr | 0.00 | — |
| Net Issuance Payments Of Debt | 0.00 | -63000.00 | -0.15 Cr | 1000.00 | — |
| Net Long Term Debt Issuance | 0.00 | -63000.00 | -0.15 Cr | 1000.00 | — |
| Long Term Debt Payments | 0.00 | -63000.00 | -0.15 Cr | 0.00 | — |
| Investing Cash Flow | -0.12 Cr | -12000.00 | -0.01 Cr | 78000.00 | — |
| Interest Received Cfi | 0.05 Cr | 0.03 Cr | 0.01 Cr | 78000.00 | — |
| Net PPE Purchase And Sale | -0.17 Cr | -0.03 Cr | -0.03 Cr | 0.00 | — |
| Operating Cash Flow | -36000.00 | 0.11 Cr | 0.65 Cr | -0.18 Cr | — |
| Taxes Refund Paid | 0.00 | 0.00 | 0.00 | -0.17 Cr | — |
| Change In Working Capital | 1.32 Cr | 0.30 Cr | 1.71 Cr | 1.32 Cr | — |
| Change In Other Current Liabilities | -0.05 Cr | -0.03 Cr | -0.10 Cr | -0.34 Cr | — |
| Change In Other Current Assets | -0.90 Cr | -0.69 Cr | -0.23 Cr | 0.78 Cr | — |
| Change In Payable | -8.11 Cr | 3.53 Cr | 8.41 Cr | 1.48 Cr | — |
| Change In Inventory | 5.44 Cr | -2.14 Cr | -2.11 Cr | -1.61 Cr | — |
| Change In Receivables | 4.93 Cr | -0.54 Cr | -4.32 Cr | 1.07 Cr | — |
| Other Non Cash Items | -0.04 Cr | 75000.00 | 0.02 Cr | -0.05 Cr | — |
| Depreciation And Amortization | 0.32 Cr | 0.34 Cr | 0.36 Cr | 0.29 Cr | — |
| Depreciation | 0.32 Cr | 0.34 Cr | 0.36 Cr | 0.29 Cr | — |
| Net Income From Continuing Operations | -1.60 Cr | -0.55 Cr | -1.43 Cr | -1.56 Cr | — |
| Net Other Investing Changes | — | 1000.00 | — | — | — |
| Net Investment Purchase And Sale | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Other Financing Charges | — | — | 1000.00 | — | — |
| Issuance Of Debt | — | — | — | 1000.00 | — |
| Net Short Term Debt Issuance | — | — | — | 0.00 | 0.00 |
| Short Term Debt Payments | — | — | — | 0.00 | 0.00 |
| Long Term Debt Issuance | — | — | — | 1000.00 | — |
| Sale Of PPE | — | — | — | 0.00 | 0.00 |
| Purchase Of PPE | — | — | — | 0.00 | 0.00 |
| Amortization Cash Flow | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Pharmasia Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.